Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,757.75
(
2.13%
)
US TECH 100
24,179.40
(
2.70%
)
Dow Jones
47,667.04
(
2.32%
)
Brent Oil
93.28
(
-7.84%
)
Bitcoin
71,194.62
(
-1.09%
)
News Focus
News Focus

Replies to post #148313 on Amarin Corp Plc (AMRN)

Replies to #148313 on Amarin Corp Plc (AMRN)
icon url

jessellivermore

10/08/18 10:34 AM

#148318 RE: Tatsumaki #148313

Tats..

Quote:

"Amarin needs to get working on their next product, not buy purified EPA makers. EPA fun time is over for them in 2029. "

Another fucking genius...

":>) JL
icon url

smarterer

10/08/18 10:51 AM

#148326 RE: Tatsumaki #148313

Tatsumaki,

EPA fun time is far from over by 2029 for AMRN. They ought to be able to get new use patents on several other diseases by then, in addition to having a volume pipeline built up with Vascepa that allows them to drive pricing to such an extent that it inhibits the ability of others--even generics--to compete.